By unleashing the power of covalent chemistry, we can deliver superior small molecule medicines with enhanced therapeutic benefit.
Total raised: $175M
Investors 2
| Date | Name | Website |
| 27.05.2022 | OrbiMed | orbimed.co... |
| 08.11.2023 | EcoR1 Capi... | ecor1cap.c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 02.11.2023 | Series B | $175M | - |
Mentions in press and media 5
| Date | Title | Description | Source |
| 20.12.2023 | Fierce Biotech Fundraising Tracker '23: Carmot spinoff Kimia... | We've launched a new Fierce Biotech Fundraising Tracker for 2023 to track all the venture capital fl... | fiercebiot... |
| 02.11.2023 | Terremoto Biosciences Closes $175 Million Series B Financing | - | orbimed.co... |
| - | Terremoto Biosciences | “By unleashing the power of covalent chemistry, we can deliver superior small molecule medicines wit... | fastfounde... |
| - | 9 top West Coast biotechs that VCs say are poised to take of... | Tayfun Coskun/Anadolu Agency/Getty Images This story is available exclusively to Insider subscribers... | businessin... |
| - | Meet the 23 biotech startups that are set to take off in the... | Tyler Le/Insider This story is available exclusively to Insider subscribers. Become an Insider and s... | businessin... |